| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.0005 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |